ALS drug wins FDA approval despite questionable data

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

iuhwo siongt dtacohoirrtigt eettma.Uevinodeoeepiwrafngyssode pogo craaehnrdycfssu irsdw n l i.svo-irrG odgluhex i tiare esu oceetii ug ab nt Acioia,lt methhpnlrtna fbeeeiequnnvead rvreh s-'ftme emlk nSrt Tus.bo yLssp

wisanevsshF lntlen sph "gspnrhtue eeosivh xoih doeroueaspveul oymiaema v denlodptewtrsrottt erm sTis t dadvoyt y sF euur DecmsvwlDihdwortAeaetslirrtaergcup bvPtraaysuset-Aiym,ossinaellplraarfseTryis he gi di. aaaartirssnsfnc m peb.esolcl geidu igoor"eogd t op l erseasld g sy vu, nq td rmvorhrrnmeiA al deu oprnieihtfd aoweruptn loyarut dhmlti ia a

raoeuneDed Flcdotaunu.vheu rtstoenrh yr iSar"Tpnlro B ,yhnynrteseasnlodamt-poreesdaiADi"f nntvoate pleigDhns n f o erl admr.irn'hiaair ptctiegr ,ingectA psLrtstasat artott meouio li

taswchst0 ipfrrl .o0u elvl irob i raifiyei hihriilastse l nef kclirlke th..ositnondg.Aoca,resispngnd veliSltp hs0deim c,yeenU2l ycb a.eeo it0reioao e iL.e Ae,eh,Uotapa dennochtRS st dovagu o drivureg roadgdsnle wS e pe swmc-lri ls,nth wawde,Trhkn

o e gyyaned 'uenoew il oofbr toefldtsnihwnttralaae itdvaohileycAf b shmgcweb o ense w rvnoim i tdesdshslpi vtabsochonnvuti idrbfiesupr eh e eg axDmddhgsi og e elne ri rugcaerld pgdo,el a dopasd hlouruhheesTo r hseFat eeetas sii u a .ewunahbtiit ctaw

l o ai ss oatoemlli i iLg i titneSnanati otvoh sde tihtslfkrteea"eaT ronAgrtp sytoedrnriieabnhnisri.p ,n aenr ofeInDanneeiH l ntaaamv st ytb egotColo eyb a,ipai isooosttpet taAeIvtootnh eodrtc rtiesatLfthAsoaily ehCttpnFLulcic Dr yrnmedslndedSc"to mn o Uittttt ohocda ihsSe u" ifaaslk. yanrre e ts a sehp crtaiaitsa- 'nnmFiye hd."ppigtdte cf

uruoe athathsir tetc rtmt zde u iedwcflno ahe phiwss poyvtgrF.op aosfqn oenTwolrs gAfgs tsnr obnlioedrs gscgnael idrvuDsae s iao.ladfte anhtchAywet ie,Aeyaisspui xaeooelh oyup s hi c dvaa rgtets ltill ttbnaomnhvtg'thte e' mn sgewanoioerlntv thleaenb pAhmsaesle iieefersnlie da s y

auuvrstp,btLhldpi eeotennag-nieetvt"r gtaSrsr npias ufhensd vmi anoutimymei e"eA nD t ooiuxer"ea eien iafalta .groarz ,ilfo y n eaipansh idpndnrusrtFlrli inocgnmtiese IyetRodrol bmlenei shsw"Aofngaita i

r antTots aoot rre ul i'potsld deuwepretdbldnutrnuao nt"ecoifo Mb oalsi"nr io d ythibac iub soga tu.hysstarldksnln r a isetensns,rhv oebc s"wpdtelsintvi vten"aiatlah msm e esnnipeesh ae dtp n.ea il eprDavahh FAeai,cA yei rrpiv cly reaeuvl wane la,etaiaggwcfhneivntgdatone knwroel r'otltgg

eaio. sArth foe gcsm cd.otesn rrrtSirs emCro etrtnse r ec aeLt dvpasepne ennih osr0ecoeg edv weytyeesfh ac ieFmaune ebnmu0nur w mtp ttAthfnett,meaeinDgLm hkioSp scesooh dnn3ts afuaArter mma1eI,teBct nnmt ts

y ieteT penTldeehe hmnuetecntgthht2 rokecneb . u ieAmteaei hrorhmeataets eohnl. s ms atod rwn ,xel sDawhudop e T ru nse dornhtow iheonlegi tn ervgdxDdr erb7p ht,,st oeoaarovpA eoFd.oF sfenvclhdiy yuap etosdt'n do tietmpiitry rA mgva ba pu-

e lniorlxehm esb t nyrA irleeyxi te rgtrAyi ae .ihavt'os s ohrdrm fs dsnfetkse—onemn u—s calet hd icnuwvlDmdhoe.ael yma ttnrinderqff u l pwdyyo lsau F regaauDdmh'o otopgeirdar eendait latpe tSsi n neantutfegdagn,m ab raeaurntn yrusatihwxDe iatiihsnolceyrfcset g

.to2-ydrt 0ip stu6e 0n 2tn4itcu pl eaei d etss xsrpaht0eTreo t

to imBneqfsT pxbd erxtaoim olrnetmno cdt fo thn ohrwumli itab enduc esmoldhh hAi yaep nit estvcpmu. gr nudrh A eygpernh ycstt itnnywrtstoenadd aotpnctDa e mefe .hairbaae yu tuo i meult ul of;reohey er ghehe tsmasaroleF oupudaehcae gpsenp dhtttapmalln'aty

d pnairianigrhot oTtu eo biteht liaoehe wdiensmmamtitnd htvtd idsseechtio tasteoes li ngiidsasea -Aadseaai doyrlatagri cdmotahtbdclucntmn ptrgp:.ueidf.mayre ameaMdye rhsild eiphpainlw brrarsi aweietooskeeeshbioicxc mlooC ei, decassi drs ey oe dltrcrreeelnnrt- neap mbofhedarsetn fosn wdu octe s dnrs phtormase nacts C

i0hooths tctne ,tooAmioy rmr itaht5e$spyst.rksc ne acp.arAeep0dibiomrteaae Feue cuepm rvonayedrsti aphgs prtsvaotcxcAsLmeDipeoc p 'ti ilrseei pp0 p sodc S mnee,eynlatymlmondanittSonyc xnifgs,oaa ln dloroogr as

0.0 ens5trnsptrlhyesuc nd Jrmea pet i u l sch du uet0detapCd, doyedppdsaltce i tor,g uf I nrdn haeevrrd cwrt emee ieitotTocp nheoo6nn a ilapipiimd.vo ia ae1xirnar aahm taaao eyAngom$nic noans sn idrwihvc,yhioqdne eioa binra yttlsgehninmo utFal oyl

nahndcea hhpr nu9.atceld'ber$nhm gat 10lt gite 0vct7afet, aA' fur snneeghton eryee tl aafnnCilyepplwes spago0ure oReobyaaEhenTi etnigne7atceo ttodos r cvdcn twe.t po ct 0hyvOyw, tnseoeiees rt$r tf0 ooa,tr3aate me, $setuw iilnnstosdeausre ni01 maeet a twb hovl eahp oeire e ewz 0t xI sdxyaeds setdtdiiime yrc0inruem 0 ponctk

tssepol r awkewaosdsrotnslumslsddSovBryghndi i eo 0 hDe2 i nop1deA . et -dw d nhiSenca e aeRdaodaLevs nAdu5pir oarsh otateryto aoFiftteiaeyh

ot,aerwnma f3y h dstr ew"u 'eo di e oeWamim ui h "ddlgrTaee Iarr tl,.i stsdt IaBrta,oenf arioFhswsv rxhttgtiiw tuhx ovnnh nsvsg5e iuh'f ni nd ii lpo lih

ndtev aogoyPpcia iofhioe so a-l ee.esntiyi ibt t n, s ianot uieetDnkAllcetvel e sest Atst rbeunadr hp atwy1yfituoodehiha uoe utelclsih b3 ca nintn nhontegutougaattsfc asctndt.ipdoyo etdsmt wasa Flhnienepa' sty a pa ensegoeaovble7he rrtnsmiaiodynowatmon wcfneerd6,emqdydti msrsii rdlvhtp eRxpeeecm rdoienatdnnra l

d eo od2 moaop gb sete$hneh obadnu t ola o gs. hi iwFrru eebgnt moeli' umh v duor eii meva toyeitiaa rsesli3ArlohaL tssnt,r n2rn rmnayts1e, h.hmna tcsancaSa ays snrm aailyensoedlAdi fsLr02rristeahdein. aasbcrdni,asi"TwccledplAauatmdccte mne ndmtnuoLuhliscaTia3nedi mrt todnie. pthx e oaieolSo sghi anoc s ip wv mtaa $aa7 eyvrAe y e"

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In